Clinical trial
Study on the Immunity Persistence Following Immunization With Enterovirus Type 71 Vaccine, Inactivated (Human Diploid Cell)
NCT07144202 is registered in ClinicalTrials.gov with Institute of Medical Biology, Chinese Academy of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on the Immunity Persistence Following Immunization With Enterovirus Type 71 Vaccine, Inactivated (Human Diploid Cell)
- Lead sponsor
- Institute of Medical Biology, Chinese Academy of Medical Sciences
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- August 10, 2025
- Completion date
- March 10, 2026
- Enrollment
- 270 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
hand, foot, and mouth disease, hand, foot, and mouth disease (hfmd)